TQVAX Mutual Fund

NAV$23.24

Fund Essentials - as of Mar 31, 2026

Net Assets
$271,008
Expense Ratio
0.99%
Dividend Yield (Current)
3.99%
Holdings
151
Inception Date
Feb 26, 2016
Fund Family
T.Rowe Price
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+13.34%
1 Year+25.39%
3 Year+17.59%
5 Year+11.56%
10 Year+11.32%

Asset Allocation

Stocks: 97.75%
Other: 2.25%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
GOOGAlphabet Inc series C3.64%
BRK.BBerkshire Hathaway, Inc.2.00%
XOMExxon Mobil Corp1.91%
BACBank Of America Corp.1.89%
JPM:USJp Morgan Chase & Co1.77%
Top 10 Concentration: 18.58%Report Date: Mar 31, 2026
Download all 151 holdings for TQVAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.99%
Frequency
Annually
Latest Distribution
$0.39
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how TQVAX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

TQVAX Mutual Fund Overview

TQVAX Mutual Fund (T. Rowe Price Integrated US Large-Cap Value Equity Fund Advisor class) is managed by T.Rowe Price with $271,008 in net assets. TQVAX expense ratio is 0.99%, holding 151 positions across sectors including Unknown, Financials, Health Care. Inception date: 2016-02-26.

TQVAX performance shows a YTD return of 13.34%. The 1-year return is 25.39% and the 5-year return is 11.56%. TQVAX dividend yield stands at 3.99%, paid annually.

TQVAX top holdings include Alphabet Inc series C (3.6%), Berkshire Hathaway, Inc. (2.0%), Exxon Mobil Corp (1.9%), Bank Of America Corp. (1.9%), Jp Morgan Chase & Co (1.8%). View all TQVAX holdings, sector breakdown, or dividend history.

TQVAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. TQVAX alternatives are available via the screener, along with tax-loss harvesting opportunities.